First Thoughts On PD With CDMOs

Kim Burson, Denali Therapeutics, Scott Zook, Primmune Therapeutics, and Knut Kiss, Mustang Bio, provide opening comments on process development at CDMOs.

Interested in the complete presentation? Click here.